This study investigates pancreatic ductal adenocarcinoma. It is focused on identifying biomarkers that could help in early detection of this condition.
The study evaluates blood markers and clinical data to improve early diagnosis and outcomes for individuals at higher than average risk of developing pancreatic ductal adenocarcinoma.
- Who can participate: Adults aged 19 and older with a family history of pancreatic cancer, cystic pancreas lesions, chronic pancreatitis, or new-onset diabetes, who can provide consent and attend study visits in Omaha, NE.
- Study details: Participants will provide blood samples twice a year. A placebo is not involved in this study.
- Study visits: The study requires 2 visits.
How understandable was the trial content above?
Hard to understand
Easy to understand